SCHEMBL3024150

SCHEMBL3024150

CCCn1c(NCc2cc(OC)ccc2O)nc2ccccc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.79
KMT2A Q03164 5/20 0.79
ALDH1A1 P00352 4/20 0.79
LMNA P02545 3/20 0.79
CASP1 P29466 1/20 0.79
HTT P42858 1/20 0.79
CASP7 P55210 1/20 0.79
MAPT P10636 7/20 0.75
POLB P06746 1/20 0.75
GAA P10253 2/20 0.74
PKM P14618 3/20 0.66
TSHR P16473 2/20 0.66
TP53 P04637 5/20 0.65
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
HPGD P15428 1/20 0.63
MAPK1 P28482 1/20 0.63
KDM4E B2RXH2 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.61
HSD17B10 Q99714 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3022255 0.86 MAPT (1.00) MEN1KMT2AALDH1A1LMNACASP1
SCHEMBL3027792 0.85 MEN1 (0.85) MEN1KMT2AALDH1A1LMNACASP1
SCHEMBL3028381 0.85 MAPT (0.88) MEN1KMT2AALDH1A1LMNACASP1
SCHEMBL3022079 0.84 MAPT (0.86) MEN1KMT2AALDH1A1LMNACASP1
SCHEMBL3017675 0.83 MEN1 (0.84) MEN1KMT2AALDH1A1LMNACASP1
SCHEMBL3021963 0.80 MAPT (0.88) MEN1KMT2AALDH1A1LMNAHTT
SCHEMBL3024864 0.77 MEN1 (0.83) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL3031459 0.76 MAPT (1.00) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL20715589 0.76 MAPT (0.91) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL3023642 0.76 MAPT (0.80) MEN1KMT2AALDH1A1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9316633-B2 Methods for identifying inhibitors of solute transporters THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-04-19 US disclosed
US-20100190796-A1 METHODS FOR IDENTIFYING INHIBITORS OF SOLUTE TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190796-A1 METHODS FOR IDENTIFYING INHIBITORS OF SOLUTE TRANSPORTERS SLC2A1, SLC2A3, SLC2A8 MEN1 1626/4885KMT2A 4412/4885ALDH1A1 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.